Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
40.06
-0.44 (-1.09%)
At close: Feb 11, 2026, 4:00 PM EST
40.05
-0.01 (-0.02%)
After-hours: Feb 11, 2026, 4:32 PM EST
Soleno Therapeutics Market Cap
Soleno Therapeutics has a market cap or net worth of $2.15 billion as of February 11, 2026. Its market cap has increased by 6.61% in one year.
Market Cap
2.15B
Enterprise Value
1.64B
1-Year Change
6.61%
Ranking
Category
Stock Price
$40.06
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $2.15B, an increase of 8,611.03%. That is a compound annual growth rate of 48.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 2.18B | -12.53% |
| Dec 31, 2025 | 2.49B | 28.31% |
| Dec 31, 2024 | 1.94B | 57.88% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
| Nov 13, 2014 | 24.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 2.41B |
| Mesoblast | 2.35B |
| Telix Pharmaceuticals | 2.34B |
| Ultragenyx Pharmaceutical | 2.33B |
| Maze Therapeutics | 2.33B |
| Ascentage Pharma Group International | 2.24B |
| Galapagos NV | 2.23B |
| Dianthus Therapeutics | 2.20B |